NCT03986684View on ClinicalTrials.gov

Molecules Associated With the Presence and Severity of Nonalcoholic Fatty Liver Disease

CompletedOBSERVATIONAL
Enrollment

32

Participants

Timeline

Start Date

January 5, 2017

Primary Completion Date

May 30, 2017

Study Completion Date

May 30, 2017

Conditions
Nonalcoholic Fatty LiverMetabolic Syndrome
Trial Locations (1)

54642

Hippokration General Hospital, Thessaloniki

All Listed Sponsors
lead

Hippocration General Hospital

OTHER

NCT03986684 - Molecules Associated With the Presence and Severity of Nonalcoholic Fatty Liver Disease | Biotech Hunter | Biotech Hunter